Announcement from the UiO Growth House: Launch of Medical Device Guidance Are you a researcher at UiO who develops medical device? At this event we introduce you to Medical Device Guidance a new innovation service from the UiO Growth House. The services gives you a step-by-step overview of the processes you have to go through to ensure that your device is developed according to regulatory requirements in EU. Time and place: March 26th, 2026 8:00 AM – 9:30 AM, Lyng, Oslo Science Park, Gaustadalléen 21, Oslo Program and registration (uio.no)
Published in Level 2 journals, first or last author from Oslo University Hospital. Misceo D, Lirussi L, Antal EA, Sikiric A, Ørstavik K, Bjørnstad PM, Sundaram AYM, Elkamil AI, Esbensen QY, Bøker T, Brorson SH, Hoddevik EH, Nilsen HL, Frengen E, Strømme P (2026) Neurogenic muscular atrophy in NHP2-related dyskeratosis congenita in a family: pathological and molecular insights Acta Neuropathol, 152 (1) DOI 10.1007/s00401-026-03088-1, PubMed 42842021 Riudavets Puig R, O'Mahony DG, Brorson IS, Sokolova K, Kristensen VN, Mathelier A (2026) HiFIseek: Gene-specific enrichment of high-impact mutations in associated genomic regions PLoS Comput Biol, 22 (10), e1014842 (in press) DOI 10.1371/journal.pcbi.1014842, PubMed 42837436 Villatoro A, Dougé A, Krpina K, Schmitz LM, Forcados C, Kaveh F, Arias-Díaz AE, Gelebart P, McCormack E, Stripecke R, Abal M, Davidson B, Inderberg EM, Wälchli S (2026) Combining TAG-72CAR with anti-MUC16CAR improves the potency of ovarian cancer treatment FEBS J (in press) DOI 10.1111/febs.70760, PubMed 42834815 More selected publications
